Literature DB >> 30958079

Long-term results of continent catheterizable urinary channels in adults with non-neurogenic or neurogenic lower urinary tract dysfunction.

Ilse M Groenendijk1, Joop van den Hoek1, Bertil F M Blok1, Rien J M Nijman2, Jeroen R Scheepe1.   

Abstract

Objectives: To evaluate the long-term results after the construction of a Continent Catheterizable Urinary Conduit (CCUC) in adults.
Methods: This study retrospectively reviewed the charts of 41 adults from two tertiary centers who received a CCUC. The demographics, underlying diseases, indications for a CCUC and outcomes such as the reoperation rate and the occurrence of complications were extracted. The patient reported outcome was measured with the Patient Global Impression of Improvement (PGI-I) scale and four additional questions about continence, leakage and stomal problems.
Results: Twenty-nine patients were women. The median age at surgery was 32 years, with a median follow-up of 52 months. Twenty-six patients had a neurogenic bladder. The reoperation rate was 48.8%, with a median of 10.5 months after constructing the CCUC. Superficial stomal stenosis was the most common registered complication (20 times) and stoma revision was the most often performed reoperation (12 times). Twenty-four patients completed the PGI-I; the mean improvement rating was 2 (=much better).
Conclusion: The construction of a CCUC in adults is associated with a high complication and reoperation rate. The high reoperation rate is in accordance with the sparse literature. Despite this, patients reported 'much better' on the PGI-I.

Entities:  

Keywords:  Urinary diversion; adults; complications; lower urinary tract symptoms

Year:  2019        PMID: 30958079     DOI: 10.1080/21681805.2019.1596156

Source DB:  PubMed          Journal:  Scand J Urol        ISSN: 2168-1805            Impact factor:   1.612


  1 in total

1.  Bone marrow mesenchymal stem cells therapy on bilateral pelvic nerve crush-induced voiding dysfunction in rats.

Authors:  Zhou Shen; Qingyu Ge; Deyun Shen; Kaiguo Xia; Jun Xiao
Journal:  Int Urogynecol J       Date:  2022-04-22       Impact factor: 1.932

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.